October 4, 2024
An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here’s […]
October 4, 2024
TOPLINE: Older adults who experience falls are at a higher risk of developing dementia within a year. The study found that 10.6% of patients who fell […]
October 3, 2024
TOPLINE: High levels of urinary cadmium are associated with double the risk for global cognitive impairment in White adults, a new study shows. There was no […]
October 2, 2024
PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson’s disease (PD) and may avoid complications associated with levodopa, […]
October 1, 2024
PHILADELPHIA — The investigational agent ecopipam reduces tic severity in children and adolescents with Tourette syndrome (TS) without exacerbating common psychiatric comorbidities, results of a new […]
October 1, 2024
When Russia occupied and annexed Crimea in 2014, Ukraine’s neurosurgeons saw a grim preview of the full-scale war that was yet to come. “We lost not […]
September 30, 2024
COPENHAGEN, Denmark — Growing evidence supports the use of highly effective disease-modifying therapies for children with multiple sclerosis (MS). However, only few of these medications are […]
September 30, 2024
Eliezer Masliah, MD, director of the neuroscience division at the National Institute on Aging (NIA), has been “relieved of his position” following an investigation by the […]
September 27, 2024
COPENHAGEN, Denmark — Women of childbearing age with multiple sclerosis (MS) receive fewer highly effective medications than men with similar levels of disability, even after accounting […]